SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-17-000218
Filing Date
2017-07-31
Accepted
2017-07-31 11:03:02
Documents
8
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ptgef_20f.htm 20-F 726129
2 MEMORANDUM AND ARTICLES OF ASSOCIATION ptgef_ex12.htm EX-1.2 214422
3 CERTIFICATION ptgef_ex121.htm EX-12.1 12029
4 CERTIFICATION ptgef_ex122.htm EX-12.2 12046
5 CERTIFICATION ptgef_ex131.htm EX-13.1 4884
6 CERTIFICATION ptgef_ex132.htm EX-13.2 4566
7 ptgef_20f002.gif GRAPHIC 6605
8 ptgef_ex12001.jpg GRAPHIC 10766
  Complete submission text file 0001393905-17-000218.txt   999338
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 000-30314 | Film No.: 17991951
SIC: 1311 Crude Petroleum & Natural Gas